CG Oncology (CGON) Gross Profit (2024 - 2026)

CG Oncology (CGON) posted Gross Profit of -$1.9 million for Q1 2026, down 151.2% on a QoQ basis from -$748000.0 in Q4 2025, and down 3713.46% year-over-year from $52000.0 in Q1 2025.

CG Oncology (CGON) Gross Profit (2024 - 2026) Analysis & Trends

CG Oncology's Gross Profit history runs 3 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

  • Quarterly Gross Profit fell 3713.46% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (changed N/A YoY) and the FY2025 annual result came in at -$607000.0, down 153.29% from the prior year.
  • Gross Profit was -$1.9 million for Q1 2026 at CG Oncology, down from -$748000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $456000.0 in Q4 2024 and bottomed at -$1.9 million in Q1 2026.
  • A 3-year average of -$331166.7 and a median of $47500.0 in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2025 — Gross Profit jumped 106.98% — and 2026, when it plunged 3713.46%.
  • CG Oncology's Gross Profit stood at $456000.0 in 2024, then plunged by 264.04% to -$748000.0 in 2025, then tumbled by 151.2% to -$1.9 million in 2026.
  • Business Quant data shows CGON's Gross Profit at -$1.9 million in Q1 2026, -$748000.0 in Q4 2025, and $89000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 CG Oncology 5.86 Bn 5.86 Bn -1.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.88 Mn
Mar 31, 2026 -1.88 Mn
Dec 31, 2025 -748,000.00
Dec 31, 2025 -748,000.00
Sep 30, 2025 89,000.00
Sep 30, 2025 89,000.00
Mar 31, 2025 52,000.00
Mar 31, 2025 52,000.00
Dec 31, 2024 456,000.00
Dec 31, 2024 456,000.00
Sep 30, 2024 43,000.00
Sep 30, 2024 43,000.00